[Recurrent respiratory papillomatoses despite vaccination].

Area of Science:

• Otolaryngology
• Virology
• Public Health

Background:

• Recurrent respiratory papillomatosis (RRP) is a chronic, debilitating airway disease caused by human papillomavirus (HPV).
• RRP manifests as wart-like lesions in the respiratory tract, leading to symptoms like dysphonia, coughing, and dyspnea.
• Currently, no curative treatment exists, and recurrent surgical intervention is the standard management to maintain airway patency.

Observation:

• A case report details a 25-year-old woman diagnosed with RRP.
• This patient developed RRP despite receiving vaccinations as per the national immunization schedule.
• Over a five-year period, she required eleven surgical procedures to manage the condition.

Findings:

• The case highlights RRP development in a vaccinated individual, questioning vaccine efficacy or coverage.
• Despite the availability of HPV vaccines that can prevent RRP, the chosen national vaccine in the Netherlands does not offer protection against this specific condition.
• This underscores a gap in preventive strategies for RRP within the national vaccination program.

Implications:

• The findings suggest a need to re-evaluate HPV vaccine selection in national programs to ensure comprehensive protection against RRP.
• Improved vaccine strategies are crucial to reduce the burden of this chronic, invalidating disease and the need for repeated surgeries.
• Public health policies should prioritize vaccines that effectively prevent HPV-related conditions like RRP to improve patient outcomes and reduce healthcare costs.